- Home
- FGEN vs FMST Comparison
FGEN vs FMST Comparison
Compare FGEN & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- FMST
- Stock Information
- Founded
- FGEN 1993
- FMST 2005
- Country
- FGEN United States
- FMST Canada
- Employees
- FGEN N/A
- FMST N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- FMST Other Metals and Minerals
- Sector
- FGEN Health Care
- FMST Basic Materials
- Exchange
- FGEN Nasdaq
- FMST Nasdaq
- Market Cap
- FGEN 45.0M
- FMST 38.2M
- IPO Year
- FGEN 2014
- FMST N/A
- Fundamental
- Price
- FGEN $11.16
- FMST $3.48
- Analyst Decision
- FGEN Strong Buy
- FMST
- Analyst Count
- FGEN 2
- FMST 0
- Target Price
- FGEN $146.50
- FMST N/A
- AVG Volume (30 Days)
- FGEN 30.7K
- FMST 513.5K
- Earning Date
- FGEN 11-11-2025
- FMST 11-21-2025
- Dividend Yield
- FGEN N/A
- FMST N/A
- EPS Growth
- FGEN N/A
- FMST N/A
- EPS
- FGEN N/A
- FMST N/A
- Revenue
- FGEN $7,346,000.00
- FMST N/A
- Revenue This Year
- FGEN N/A
- FMST N/A
- Revenue Next Year
- FGEN N/A
- FMST N/A
- P/E Ratio
- FGEN N/A
- FMST N/A
- Revenue Growth
- FGEN N/A
- FMST N/A
- 52 Week Low
- FGEN $4.50
- FMST $0.55
- 52 Week High
- FGEN $21.94
- FMST $5.74
- Technical
- Relative Strength Index (RSI)
- FGEN 46.07
- FMST 59.53
- Support Level
- FGEN $11.36
- FMST $2.94
- Resistance Level
- FGEN $12.13
- FMST $3.52
- Average True Range (ATR)
- FGEN 0.54
- FMST 0.24
- MACD
- FGEN -0.20
- FMST 0.03
- Stochastic Oscillator
- FGEN 8.97
- FMST 86.57
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.